Credential Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.28M Sell
37,199
-2,411
-6% -$82.4K 0.29% 54
2018
Q1
$1.33M Buy
39,610
+2,288
+6% +$78.7K 0.32% 53
2017
Q4
$1.28M Sell
37,322
-1,025
-3% -$35K 0.31% 60
2017
Q3
$1.3M Buy
38,347
+1,022
+3% +$32.8K 0.35% 57
2017
Q2
$1.19M Buy
37,325
+857
+2% +$27K 0.36% 56
2017
Q1
$1.18M Buy
36,468
+300
+0.8% +$9.46K 0.41% 51
2016
Q4
$1.11M Buy
36,168
+388
+1% +$11.8K 0.44% 53
2016
Q3
$1.15M Buy
35,780
+524
+1% +$17.5K 0.52% 52
2016
Q2
$1.18M Buy
35,256
+274
+0.8% +$8.74K 0.61% 39
2016
Q1
$983K Sell
34,982
-8,479
-20% -$242K 0.57% 46
2015
Q4
$1.33M Buy
43,461
+861
+2% +$27.1K 0.87% 28
2015
Q3
$1.27M Buy
42,600
+6,882
+19% +$221K 0.88% 29
2015
Q2
$1.14M Buy
35,718
+1,612
+5% +$52.5K 0.72% 35
2015
Q1
$1.13M Buy
34,106
+1,238
+4% +$39.4K 0.73% 34
2014
Q4
$971K Buy
32,868
+1,571
+5% +$45K 0.63% 40
2014
Q3
$884K Buy
31,297
+1,863
+6% +$52.3K 0.59% 42
2014
Q2
$829K Buy
29,434
+2,716
+10% +$77.4K 0.55% 46
2014
Q1
$814K Buy
+26,718
New +$797K 0.61% 41

Other funds holding PFE

Credential Securities's PFE Position: Q2 2018 in Review

Credential Securities reduced its Pfizer (PFE) stake by 6.1% in Q2 2018, selling an estimated $82.4K and leaving 37,199 shares worth $1.28M. The position accounts for 0.29% of the portfolio, ranked #54.

Credential Securities first reported a position in PFE in Q1 2014 and has held it in 18 quarters since. The position peaked at $1.33M in Q1 2018. 2,205 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Credential Securities held 37,199 shares of Pfizer worth $1.28M as of Q2 2018.
  • Credential Securities sold 2,411 Pfizer shares in Q2 2018, an estimated $82.4K.
  • Pfizer made up 0.29% of Credential Securities's portfolio in Q2 2018, its #54 holding.
  • Credential Securities first reported a position in Pfizer in Q1 2014 and has held it in 18 quarters since.
  • Credential Securities's Pfizer position peaked at $1.33M in Q1 2018.
  • 2,205 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.